Dr. Anjali Varma, MD

Claim this profile

Salem VA Medical Center, Salem, VA

Studies Opiate Dependence
Studies Opioid Use Disorder
2 reported clinical trials
6 drugs studied

Affiliated Hospitals

Image of trial facility.
Salem VA Medical Center, Salem, VA

Clinical Trials Anjali Varma, MD is currently running

Image of trial facility.

Medications

for PTSD-Related Insomnia

Many Veterans with posttraumatic stress disorder (PTSD) have trouble sleeping or have frequent nightmares. So far, no medication has been approved for treatment of insomnia in PTSD. The purpose of this research study is to find out if taking medications called trazodone or eszopiclone can help decrease symptoms of insomnia in patients with PTSD. PTSD is a form of intense anxiety which sometimes results from severe trauma. Symptoms may include nightmares, flashbacks, troublesome memories, difficulty sleeping, poor concentration, irritability, anger, and emotional withdrawal. Insomnia is a disorder that can make it hard to fall sleep, stay asleep or cause a person to wake up too early and not be able to fall back to sleep.
Recruiting1 award Phase 32 criteria
Image of trial facility.

Buprenorphine Forms

for Opioid Use Disorder

VA-BRAVE will determine whether a 28-day long-acting injectable sub-cutaneous formulation of buprenorphine at a target dose of 300mg is superior in retaining Veterans in opioid treatment and in sustaining opioid abstinence compared to the daily sublingual (under the tongue) buprenorphine formulation at a target dose of 4-32 mg (standard of care). This is an open-label, randomized, controlled trial including 952 Veterans with opioid use disorder (OUD) recruited over 7 years and followed actively for 52 weeks. There are a number of secondary objectives that will be studied as well and include: comorbid substance use, both non-fatal and fatal opioid overdose, HIV and Hepatitis B (HBV) and C (HCV) testing results and risk behaviors, incarceration, quality of life, psychiatric symptoms of depression and posttraumatic stress disorder, housing status, dental health and utilization, and cost-effectiveness.
Recruiting3 awards Phase 43 criteria

More about Anjali Varma, MD

Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Anjali Varma, MD has experience with
  • Injectable Subcutaneous Buprenorphine
  • Sublingual Buprenorphine With Naloxone
  • Eszopiclone
  • Gabapentin
  • Placebo
  • Trazodone
Breakdown of trials Anjali Varma, MD has run

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Anjali Varma, MD specialize in?
Is Anjali Varma, MD currently recruiting for clinical trials?
Are there any treatments that Anjali Varma, MD has studied deeply?
What is the best way to schedule an appointment with Anjali Varma, MD?
What is the office address of Anjali Varma, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security